Global Biocompatible 3D Printing Materials Market Growing at A CAGR of 13.0% 2026


The global biocompatible 3D printing materials market was valued at USD 394.7 million in 2018 and is expected to reach USD 1,012.2 million in 2026, growing at a CAGR of 13.0% during the forecast period.

The biocompatible 3D printing materials are used in various medical applications including prototyping & surgical guides, implants & prosthesis, hearing aid, tissue engineering, and others. The 3D printing technologies are developed to enhance the unique design freedom. The biocompatible 3D printing materials are becoming popular due to its reduced lead time and excessive costs owing to tool-less processes.

Growing pharmaceutical industries, growing demand for biocompatible 3D printing materials, particularly in the implants & prosthesis application, and mass customization of biocompatible 3d printing materials and reduced production time and specifically tailored products are the main drivers for the market growth of the global biocompatible 3D printing materials market over the forecast period.


Moreover, the increase in research and development in new medicals applications across the globe is expected to enhance the market size. This also expected to open investment opportunities in the global market for the manufacturers in the coming years. The rise in adoption of 3d printing technology in bioprinting organs and increase in government spending in 3D printing offers huge growth opportunities for biocompatible 3D printing materials market in the coming years.

However, high cost of materials and complexity of design are expected to hamper the growth of the global biocompatible 3D printing materials market during the forecast period. Moreover, producing low-cost 3d printing materials and developing FDA compliant 3d printing biomaterials are the prime challenges in the global biocompatible 3D printing materials market throughout the forecast period.

The polymer segment expected to dominate the market throughout the forecast period Based on type, the global biocompatible 3D printing materials market has been segmented into polymer, metal, and others. The polymer segment accounted for approximately 24% of the share in the global biocompatible 3D printing materials market in 2018. The major factors that are driving the growth of this segment are the rising demand of polymer due to cheaper, easily moldable, and degradable and used in various applications such as tissue engineering, hearing aids, prototyping, and surgical guides.


Based on form, the powder segment is expected to dominate during the forecast period Based on form, the market has been segmented into powder, liquid, and others. The powder segment accounts of the largest share in the market and held for more than 50% of the total market in 2018. The major factors that are driving the growth of this segment are the compatibility with several 3D printers and rising demand from medical applications such as bio fabrication, implants & prosthesis, and surgical instruments.

Based on application, the tissue engineering segment is expected to dominant the market during the forecast period Based on application, the market has been segmented into implants & prosthesis, prototyping & surgical guides, tissue engineering, hearing aid, and others. The tissue engineering application segment accounts of the largest share in the global biocompatible 3D printing materials market by application.

The major factors that are driving the growth of this segment are the growing cases of tissue or organ failure due to age, diseases, accidents, and congenital disabilities and growth in research and development made on bio fabrication of body parts and organ printing. The manufacturers Evonik Industries AG, 3D Systems, Inc., and Stratasys Ltd are the mainly investing in the development of tissue engineering for the biocompatible 3D printing materials, which expected the lead the market in the coming years.


North America to dominate the biocompatible 3D printing materials market throughout the forecast period North America accounted for nearly 43% share of the global biocompatible 3D printing materials market in 2018 and is expected to dominate the market throughout the forecast period. Increasing government investments in 3D printing, well-established research, and development centers and rise in a number of manufacturers and a strong economy to support research funding are the major driving factor for the region in the global market.

Asia-Pacific is expected to hold the highest CAGR in the global market during the forecast period. The manufacturers are investing in the development of biocompatible 3D printing materials, growing demand for biocompatible 3D printing materials in developing countries and rising awareness about healthcare are expected to enhance the market growth in the global biocompatible 3D printing materials market during the forecast.

Company Profiles and Competitive Intelligence:

The major players operating in the global biocompatible 3D printing materials market are
·        Evonik Industries AG (Germany),
·        3D Systems, Inc. (US),
·        Stratasys Ltd. (US),
·        Concept Laser,
·        GmBH (Germany),
·        EOS GmBH Electro Optical Systems (Germany),
·        Renishaw PLC. (UK),
·        Formlabs Inc. (US),
·        EnvisionTEC, Inc. (Germany),
·        3D Composites (US),
·        Aspect Biosystems Ltd. (Canada)
·        Among others.

Contact Us:
Name: Steven Samuel
Phone - +91 9370882135

Comments

Popular posts from this blog

Flight Instruments : Global Size, Share, Trends, Overview, Forecast by 2023

Global Low Friction Coatings Market provides an in-depth insight of Sales and Trends Forecast to 2024

Global Lightning As A Service Market Growing At A CAGR Of Approximately 37.2% by 2026